<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sergey</forename><surname>Nikitenko</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annette</forename><surname>Rompel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alfred</forename><surname>Hummer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">51FF9A51E124057E53BD5759D5A81BD4</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T23:10+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>XAS study of Ruthenium anticancer drugs in tumor tissue</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report: Aims of the experiment and scientific background</head><p>Ruthenium compounds belong to the most promising candidates of non-platinum containing metal complexes for cancer therapy. Compared to Pt drugs Ru complexes cause less side effects and resistances against the drug are less likely. 1,2 The overall chemical and pharmacokinetic behavior of Ru is quite different from Pt compounds, as reflected in extensive protein binding 3 which questions the relevance of DNA interactions in vivo. KP1019 (indazolium-trans-[tetrachlorobis(indazole)ruthenate(III)]), 4,5 and its sodium analogue KP1339 (sodium-trans-[tetrachlorobis(indazole)ruthenate(III)]) 4,5 are very promising drug candidates currently under investigation. The redox potential of Ru(III)/Ru(II) is physiologically accessible and the activation of the drugs through reduction to Ru(II) is thought to play an important role in their mode of action. Therefore Xray absorption spectroscopy was used to find out which oxidation state of the tumor-inhibiting compound and which first coordination sphere in vitro and in vivo is most likely. A database of different ruthenium compounds representing possible first coordination spheres and oxidation states in vivo was established. Spectra of KP1019 in BN and mice tissues (tumor S-180 and liver) from KP1019 and KP1339 treated mice were collected. The aim of the study is a fundamental understanding of the biotransformation of the ruthenium complexes KP1019 and KP1339 in biological tissue, and the underlying principle of "activation by reduction". Information about possible oxidation state/ coordination pairings will give insight into the in vivo metabolism of these metallodrugs and reassess the interaction with the hypothesized molecular targets.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>XANES and EXAFS spectra were collected at the Ru K-edge at 20 K. Ru powder was used as a reference compound for the energy calibration and to check the monochromator stability. The samples were enclosed in Kapton sealed aluminum sample holders. EXAFS spectra of Ru model compounds with mixed first coordination shells of Cl, N, O and S in oxidation states +2 and +3 were colected. K-edge spectra of KP1019 in the prescence of different possible biological target molecules and of tissue samples derived from KP1339 treated mice were collected as well.</p><p>In Fig. <ref type="figure" target="#fig_0">1</ref> (left) and (right) the XANES spectra of the model compounds are shown. Their egde positions are clearly influenced by two phenomena, the oxidation state of the ruthenium center and the electronegativity of the sourrounding ligands. The complexes with higher oxidation state and more electronegative ligands are shifted to higher energy positions. As described in 6 a correlation of the edge position and the calculated coordination charge can be drawn. The electronegativity values of S, Cl, N and O were taken form the Allred-Rochow scale and are 2.4, 2.8, 3.1 and 3.5, respectively. The coordination charges are plotted over the edge energy values in Fig. <ref type="figure" target="#fig_1">2</ref> (right), with KP1019 set as an arbitrary zero point. The edge energies were determined over the first maximum in the first derivative. In Fig. <ref type="figure" target="#fig_1">2</ref> (left) the XANES spectra of a tumor and liver tissue in comparison to KP1019 in boron nitride are shown. The coordination of KP1019 in the two tissue samples seems to be the same but different from the pure Ru-drug. The edge shift of the biological samples and KP1019 in buffer in comparison to KP1019 as a solid is shown in Fig. <ref type="figure" target="#fig_1">2</ref> (left).  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 :</head><label>1</label><figDesc>Fig. 1: XANES spectra of the chlorine and sulfur rich models (left) and the nitrogen and oxygen rich models (right).</figDesc><graphic coords="2,63.42,381.36,234.48,152.88" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 :</head><label>2</label><figDesc>Fig. 2: XANES spectra of a tumor and liver sample (left) and the coordination charge versus energy plot (right).</figDesc><graphic coords="2,297.66,383.52,234.48,150.72" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Antitumour metal compounds: more than theme and variations</title>
		<author>
			<persName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mathea</forename><forename type="middle">S</forename><surname>Galanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vladimir</forename><forename type="middle">B</forename><surname>Arion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><forename type="middle">G</forename><surname>Hartinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<idno type="DOI">10.1039/b712656p</idno>
	</analytic>
	<monogr>
		<title level="j">Dalton Transactions</title>
		<title level="j" type="abbrev">Dalton Trans.</title>
		<idno type="ISSN">1477-9226</idno>
		<idno type="ISSNe">1477-9234</idno>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="183" to="194" />
			<date type="published" when="2008">2008</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Jakupec, M. A.; Galanski, M.; Arion, V. B.; Hartinger, C. G.; Keppler, B. K. Dalton Trans. 2008, 183.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Intrinsic and Acquired Forms of Resistance against the Anticancer Ruthenium Compound KP1019 [Indazolium trans-[tetrachlorobis(1 H-indazole)ruthenate (III)] (FFC14A)</title>
		<author>
			<persName><forename type="first">P</forename><surname>Heffeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pongratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Elbling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Marian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Körner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sevelda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Micksche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Berger</surname></persName>
		</author>
		<idno type="DOI">10.1124/jpet.104.073395</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Pharmacology and Experimental Therapeutics</title>
		<title level="j" type="abbrev">The Journal of Pharmacology and Experimental Therapeutics</title>
		<idno type="ISSN">0022-3565</idno>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="281" to="289" />
			<date type="published" when="2005-01">2005</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Heffeter, P.; Pongratz, M.; Steiner, E.; Chiba, P.; Jakupec, M. A.; Elbling, L.; Marian, B.; Körner, W.; Sevelda, F.; Micksche, M.; Keppler, B. K.; Berger, W. Journal of Pharmacology and Experimental Therapeutics 2005, 312, 281-289.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</title>
		<author>
			<persName><forename type="first">Petra</forename><surname>Heffeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katharina</forename><surname>Böck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bihter</forename><surname>Atil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mir</forename><forename type="middle">Ali</forename><surname>Reza Hoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wilfried</forename><surname>Körner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caroline</forename><surname>Bartel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ute</forename><surname>Jungwirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Micksche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Walter</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gunda</forename><surname>Koellensperger</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00775-010-0642-1</idno>
	</analytic>
	<monogr>
		<title level="j">JBIC Journal of Biological Inorganic Chemistry</title>
		<title level="j" type="abbrev">J Biol Inorg Chem</title>
		<idno type="ISSN">0949-8257</idno>
		<idno type="ISSNe">1432-1327</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="737" to="748" />
			<date type="published" when="2010-03-11">2010</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Heffeter, P.; Böck, K.; Atil, B.; Reza Hoda, M.; Körner, W.; Bartel, C.; Jungwirth, U.; Keppler, B.; Micksche, M.; Berger, W.; Koellensperger, G. Journal of Biological Inorganic Chemistry 2010, 15, 737-748.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Synthesis, Characterization and Solution Chemistry of&lt;i&gt;trans&lt;/i&gt;‐Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a NewAnticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations andAntitumor Activity. Crystal Structures of &lt;i&gt;trans&lt;/i&gt;‐1‐Methyl‐Indazoliumtetrachlorobis‐(1‐Methylindazole)Ruthenate(III)and its Hydrolysis Product &lt;i&gt;trans&lt;/i&gt;‐Monoaquatrichlorobis‐(1‐Methylindazole)‐Ruthenate(III)</title>
		<author>
			<persName><forename type="first">Kari-Georg</forename><surname>Lipponer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ellen</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<idno type="DOI">10.1155/mbd.1996.243</idno>
	</analytic>
	<monogr>
		<title level="j">Metal-Based Drugs</title>
		<title level="j" type="abbrev">Metal-Based Drugs</title>
		<idno type="ISSN">0793-0291</idno>
		<idno type="ISSNe">1687-5486</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="243" to="260" />
			<date type="published" when="1996-01">1996</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Lipponer, K.-G.; Vogel, E.; Keppler, B. K. Synthesis, Characterization and Solution Chemistry 1996, 3, 243-260.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Synthesis of Tumor-Inhibiting Complex Salts Containing the Aniontrans-Tetrachlorobis(indazole)ruthenate(III) and Crystal Structure of the Tetraphenylphosphonium Salt</title>
		<author>
			<persName><forename type="first">Wolfgang</forename><surname>Peti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Thomas</forename><surname>Pieper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Martina</forename><surname>Sommer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gerald</forename><surname>Giester</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1099-0682(199909)1999:9&lt;1551::aid-ejic1551&gt;3.0.co;2-7</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Inorganic Chemistry</title>
		<title level="j" type="abbrev">Eur. J. Inorg. Chem.</title>
		<idno type="ISSN">1434-1948</idno>
		<idno type="ISSNe">1099-0682</idno>
		<imprint>
			<biblScope unit="volume">1999</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1551" to="1555" />
			<date type="published" when="1999-09">1999. 1999</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Peti, W.; Pieper, T.; Sommer, M.; Keppler, B. K.; Giester, G. European Journal of Inorganic Chemistry 1999, 1999, 1551-1555.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Molybdenum x-ray absorption edge spectra. The chemical state of molybdenum in nitrogenase</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Eccles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Kutzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Keith</forename><forename type="middle">O</forename><surname>Hodgson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Mortenson</surname></persName>
		</author>
		<idno type="DOI">10.1021/ja00421a053</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Chemical Society</title>
		<title level="j" type="abbrev">J. Am. Chem. Soc.</title>
		<idno type="ISSN">0002-7863</idno>
		<idno type="ISSNe">1520-5126</idno>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1287" to="1288" />
			<date type="published" when="1976-03">1976</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Cramer, S. P.; Eccles, T. K.; Kutzler, F. W.; Hodgson, K. O.; Mortenson, L. E. Journal of the American Chemical Society 1976, 98, 1287-1288.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
